Main Article Content Jonathan I. Silverberg Mark Boguniewicz Kim Papp Athanasios Tsianakas Pinaki Biswas Claire Feeney Mark Levenberg Keywords Abrocitinib, JAK1 inhibitor, Moderate-to-Severe Atopic Dermatitis, JADE REGIMEN References 1. Boguniewicz M et al. Ann Allergy Asthma Immunol. 2018;120:10-22. 2. Blauvelt A et al. J Am Acad Dermatol. 2022;86:104-112. Article Sidebar Article Details How to Cite Silverberg, J. I. ., Boguniewicz, M., Papp, K., Tsianakas, A., Biswas, P., Feeney, C., & Levenberg, M.